Type 2 deiodinase expression is stimulated by growth factors in human vascular smooth muscle cells

Molecular and Cellular Endocrinology

Volumn 200, Issue 1-2, 2003, Pages 111-117

  Maeda, Akimasa ^a   Toyoda, Nagaoki ^a   Yasuzawa Amano, Saori ^a   Iwasaka, Toshiji ^a   Nishikawa, Mitsushige ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Basic fibroblast growth factor; Deiodinase; Platelet derived growth factor; Thyroid hormone; Vascular smooth muscle cell

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BASIC FIBROBLAST GROWTH FACTOR; ENZYME; ENZYME INHIBITOR; GROWTH FACTOR; IODOTHYRONINE DEIODINASE TYPE 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PLATELET DERIVED GROWTH FACTOR BB; RNA; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

AORTA MEDIA; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RNA SYNTHESIS; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANTHRACENES; CYCLOHEXIMIDE; DACTINOMYCIN; FIBROBLAST GROWTH FACTOR 2; FLAVONOIDS; GENE EXPRESSION REGULATION; HUMANS; IMIDAZOLES; IODIDE PEROXIDASE; MUSCLE, SMOOTH, VASCULAR; PROTO-ONCOGENE PROTEINS C-SIS; PYRIDINES; RNA, MESSENGER;

EID: 0037469657     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(02)00409-4     Document Type: Article

References (36)

1. Barrett T.B., Benditt E.P. Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc. Natl. Acad. Sci. USA. 85:1988;2810-2814.
2. Bartha T., Kim S.W., Salvatore D., Gereben B., Tu H.M., Harney J.W., Rudas P., Larsen P.R. Characterization of the 5′-flanking and 5′-untranslated region of the cyclic adenosine 3′,5′-monophosphate-responsive human type 2 iodothyronine deiodinase gene. Endocrinology. 141:2000;229-237.
3. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA. 98:2001;13681-13686.
4. Bianco A.C., Salvatore D., Gereben B., Berry M.J., Larsen P.R. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr. Rev. 23:2002;38-89.
5. Bikfalvi A., Klein S., Pintucci G., Rifkin D.B. Biological roles of fibroblast growth factor-2. Endocr. Rev. 18:1997;26-45.
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
7. Burmeister L.A., Pachucki J., St. Germain D.L. Thyroid hormones inhibit type 2 iodothyronine deiodinase in the rat cerebral cortex by both pre- and post-translational mechanisms. Endocrinology. 138:1997;5231-5237.
8. Canettieri G., Celi F.S., Baccheschi G., Salvatori L., Andreoli M., Centanni M. Isolation of human type 2 deiodinase gene promoter and characterization of a functional cyclic adenosine monophosphate response element. Endocrinology. 141:2000;1804-1813.
9. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
10. Croteau W., Davey J.C., Galton V.A., St. Germain D.L. Cloning of the mammalian type II iodothyronine deiodinase: a selenoprotein differentially expressed and regulated in human and rat brain and other tissues. J. Clin. Invest. 98:1996;405-417.
11. Dudley D.T., Pang L., Decker S.J., Bridges A.J., Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA. 92:1994;7686-7689.
12. Force T., Bonventre J.V. Growth factors and mitogen-activated protein kinases. Hypertension. 31:1998;152-161.
13. Hernandez A., Obregon M.J. Presence of growth factor-induced type III iodothyronine 5-deiodinase in cultured rat brown adipocytes. Endocrinology. 136:1995;4543-4550.
14. Hernandez A., St. Germain D.L., Obregon M.J. Transcriptional activation of type III inner ring deiodinase by growth factors in cultured rat brown adipocytes. Endocrinology. 139:1998;634-639.
15. Hosoi Y., Murakami M., Mizuma H., Ogiwara T., Imamura M., Mori M. Expression and regulation of type II iodothyronine deiodinase in cultured human skeletal muscle cells. J. Clin. Endocrinol. Metab. 84:1999;3293-3300.
16. Hughes S.E., Crossman D., Hall P.A. Expression of basic and acidic fibroblast growth factors and their receptors in normal and atherosclerotic human arteries. Cardiovasc. Res. 27:1993;1214-1219.
17. Hughes A.D., Clunn G.F., Refson J., Demoliou-Mason C. Platelet-derived growth factor (PDGF): actions and mechanisms in vascular smooth muscle. Gen. Pharmacol. 27:1996;1079-1089.
18. Imai Y., Toyoda N., Maeda A., Kadobayashi T., Wang F., Kuma K., Nishikawa M., Iwasaka T. Type 2 iodothyronine deiodinase expression is upregulated by the PKA-dependent and is downregulated by the PKC-dependent pathways in cultured human thyroid cells. Thyroid. 11:2001;899-907.
19. Kim S.W., Harney J.W., Larsen P.R. Studies of the hormonal regulation of type 2 5′-iodothyronine deiodinase messenger ribonucleic acid in pituitary tumor cells using semiquantitative reverse transcription-polymerase chain reaction. Endocrinology. 139:1998;4895-4905.
20. Koehrle J. Local activation and inactivation of the thyroid hormones: the deiodinase family. Mol. Cell. Endocrinol. 151:1999;103-119.
21. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., Green D., McNulty D., Blumenthal M.J., Heys J.R., Landvatter S.W., Strickler J.E., McLaughlin M.M., Siemens I.R., Fisher S.M., Livi G.P., White J.R., Adams J.L., Young P.R. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 372:1994;739-746.
22. Leonard J.L., Visser T.J. Biochemistry of Deiodination (Thyroid Hormone Metabolism). 1986;189-229 Marcel Dekker, New York.
23. Libby P., Warner S.J., Salomon R.N., Birinyi L.K. Production of platelet-derived growth factor-like mitogen by smooth muscle cells from human atheroma. N. Engl. J. Med. 318:1988;1493-1498.
24. Mizuma H., Murakami M., Mori M. Thyroid hormone activation in human vascular smooth muscle cells. Circ. Res. 88:2001;313-318.
25. Pallud S., Ramauge M., Gavaret J.M., Lennon A.M., Munsch N., St. Germain D.L., Pierre M., Courtin F. Regulation of type 3 iodothyronine deiodinase expression in cultured rat astrocytes: role of the ERK cascade. Endocrinology. 140:1999;2917-2923.
26. Reidy M.A. Neointimal proliferation: the role of basic FGF on vascular smooth muscle cell proliferation. Thromb. Haemost. 70:1993;172-176.
27. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340:1999;115-126.
28. Ross R., Raines E.W., Bowen-Pope D.F. The biology of platelet-derived growth factor. Cell. 46:1986;155-169.
29. Sachinidis A., Locher R., Vetter W., Tatje D., Hoppe J. Different effects of platelet-derived growth factor isoforms on rat vascular smooth muscle cells. J. Biol. Chem. 265:1990;10238-10243.
30. Sachinidis A., Schulte K., Ko Y., Meyer zu Brickwedde M.K., Hoppe V., Hoppe J., Vetter H. The induction of early response genes in rat smooth muscle cells by PDGF-AA is not sufficient to stimulate DNA synthesis. FEBS Lett. 319:1993;221-224.
31. Salvatore D., Bartha T., Harney J.W., Larsen P.R. Molecular biology and biochemical characterization of the human type 2 selenodeiodinase. Endocrinology. 137:1996;3308-3315.
32. Salvatore D., Tu H., Harney J.W., Larsen P.R. Type 2 iodothyronine deiodinase is highly expressed in human thyroid. J. Clin. Invest. 98:1996;962-968.
33. Steinsapir J., Bianco A.C., Buettner C., Harney J.W., Larsen P.R. Substrate-induced down-regulation of human type 2 deiodinase is mediated through proteasomal degradation and requires interaction with the enzyme's active center. Endocrinology. 141:2000;1127-1135.
34. St. Germain D.L., Galton V.A. The deiodinase family of selenoproteins. Thyroid. 7:1997;655-668.
35. Tu H.M., Kim S.W., Salvatore D., Bartha T., Legradi G., Larsen P.R., Lechan R.M. Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone. Endocrinology. 138:1997;3359-3368.
36. Wilcox J.N., Smith K.M., Williams L.T., Schwartz S.M., Gordon D. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J. Clin. Invest. 82:1988;1134-1143.